CNPOF (RIV Capital) Days Inventory : 170.76 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is RIV Capital Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). RIV Capital's Average Total Inventories for the three months ended in Sep. 2024 was $11.26 Mil. RIV Capital's Cost of Goods Sold for the three months ended in Sep. 2024 was $6.02 Mil. Hence, RIV Capital's Days Inventory for the three months ended in Sep. 2024 was 170.76.

The historical rank and industry rank for RIV Capital's Days Inventory or its related term are showing as below:

CNPOF' s Days Inventory Range Over the Past 10 Years
Min: 0 Med: 0 Max: 288.06
Current: 288.06

During the past 5 years, RIV Capital's highest Days Inventory was 288.06. The lowest was 0.00. And the median was 0.00.

CNPOF's Days Inventory is ranked worse than
83.6% of 945 companies
in the Drug Manufacturers industry
Industry Median: 156.81 vs CNPOF: 288.06

RIV Capital's Days Inventory declined from Sep. 2023 (577.94) to Sep. 2024 (170.76).

Inventory Turnover measures how fast the company turns over its inventory within a year. RIV Capital's Inventory Turnover for the three months ended in Sep. 2024 was 0.53.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. RIV Capital's Inventory-to-Revenue for the three months ended in Sep. 2024 was 2.32.

RIV Capital Days Inventory Historical Data

The historical data trend for RIV Capital's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital Days Inventory Chart

RIV Capital Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Days Inventory

RIV Capital Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Inventory	Get a 7-Day Free Trial															577.94	507.29	809.58	220.03	170.76

Competitive Comparison of RIV Capital's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RIV Capital's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's Days Inventory distribution charts can be found below:

* The bar in red indicates where RIV Capital's Days Inventory falls into.

RIV Capital Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

RIV Capital's Days Inventory for the fiscal year that ended in Mar. 2022 is calculated as

	Days Inventory (A: Mar. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2021 )	+	Total Inventories (A: Mar. 2022 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

RIV Capital's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:

	Days Inventory (Q: Sep. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2024 )	+	Total Inventories (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (12.29	+	10.237)	/	2 )	/	6.019	*	365 / 4
=	11.2635					/	6.019	*	365 / 4
=	170.76

RIV Capital (OTCPK:CNPOF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

RIV Capital's Inventory Turnover for the three months ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	6.019	/	11.2635
	=	0.53

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

RIV Capital's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	11.2635	/	4.859
	=	2.32

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

RIV Capital Days Inventory Related Terms

Thank you for viewing the detailed overview of RIV Capital's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

RIV Capital Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (OTCPK:CNPOF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

RIV:Canada

Address

40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2

Website

https://www.rivcapital.com

RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.